Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
The federal preemption of state tort law is an issue in several cases on the Supreme Court’s docket, including February 25 oral arguments in Warner-Lambert v. Kent. The Supreme Court also recently agreed to hear early next term appeals in the cases of Wyeth v. Levine, in which the federal...
The Supreme Court's Wyeth decision will hurt new drug development and limit physicians' willingness to use certain drugs.
The Supreme Court's 2008-2009 term brought modest progress on civil rights, a personnel change that is unlikely to alter the Court's balance, and massive confusion and backpedaling on "business cases."
We should be cautiously optimistic about future developments as important cases about federal preemption and the scope of securities laws come before the SupremeCourt in 2007.
The Supreme Court's decision in Wyeth v. Levine could lead the FDA to require excessive warnings on medications and impose "contraindications" that would constrain medical practice.
If the legislature will not act responsibly, courts should aggressively protect the constitutional rights of parties when retroactive legislation creates new liabilities for past conduct.
The Roberts Court's business cases suggest that it is finally stepping away from the culture wars and returning to the nuts and bolts of law.
In a large population of elderly patients with acute myocardial infarction, we found significant treatment differences but no significant incremental mortality benefit associated with treatment by cardiologists.



